News Article

Saneron and USF Patent Method for Umbilical Cord Blood Cell Use
Date: Mar 05, 2013
Source: ( click here to go to the source)

Featured firm in this article: Saneron CCEL Therapeutics Inc of Tampa, FL

Newswise — TAMPA, Fla. - March 05, 2013 -- Researchers at Saneron CCEL Therapeutics, Inc. of Tampa, Florida, ( and the University of South Florida have received a patent relating to a method for obtaining and using umbilical cord blood cells from a donor or patient to provide neural cells for transplantation aimed at repairing a variety of neurodegenerative diseases of the brain and spinal cord, such as Parkinson's disease, Huntington's disease, multiple sclerosis, Alzheimer's disease as well as brain and spinal cord injury.